Omega reports negative growth in its sales & earnings in fiscal 2024. OFLX continues to print lower highs and lower lows, pointing to lower prices ahead. Due to inflation pressures which may be ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. If you are looking at Omega Healthcare Investors and wondering whether the current ...

Omega Flex's stock remains a 'Hold' due to ongoing technical weakness and a lack of confirmed bottom despite steeply discounted valuation. Q3 fiscal 2024 results show a 9.5% decline in net sales and a ...

BofA raised the firm’s price target on Omega Healthcare (OHI) to $43 from $39 and keeps a Neutral rating on the shares. For the second consecutive quarter, the company has exceeded the firm’s ...

These Omegas now represent genuine value ...